2023
Analysis of Repair Type and Hypogastric Artery Antegrade Perfusion and Erectile Function following Repair of Abdominal Aortic Aneurysms
Bennett K, Hurley L, Kyriakides T, Matsumura J, Group O. Analysis of Repair Type and Hypogastric Artery Antegrade Perfusion and Erectile Function following Repair of Abdominal Aortic Aneurysms. Annals Of Vascular Surgery 2023, 94: 186-194. PMID: 37164171, DOI: 10.1016/j.avsg.2023.04.025.Peer-Reviewed Original ResearchConceptsErectile functionArtery perfusionErectile dysfunctionHypogastric flowEndovascular repairAneurysm repairAortic aneurysmAntegrade perfusionPreoperative ankle-brachial indexErectile Function-5 (IIEF-5) questionnaireAbdominal aortic aneurysm repairHypogastric artery exclusionSignificant erectile dysfunctionThoracic aortic proceduresAnkle-brachial indexBeta-blocker useFifth of patientsSpinal cord ischemiaAortic aneurysm repairAbdominal aortic aneurysmMixed effects regression modelsBranched deviceButtock claudicationEndovascular groupBlocker use
2022
Effect of preservation of antegrade hypogastric flow on development of claudication following aortoiliac aneurysm repair
Bennett K, Hurley L, Kyriakides T, Yi J, Freischlag J, Matsumura J, Group O. Effect of preservation of antegrade hypogastric flow on development of claudication following aortoiliac aneurysm repair. Journal Of Vascular Surgery 2022, 77: 1070-1076. PMID: 36565778, DOI: 10.1016/j.jvs.2022.12.022.Peer-Reviewed Original ResearchConceptsAortoiliac aneurysm repairDevelopment of claudicationButtock claudicationHypogastric flowClaudication symptomsHypogastric perfusionAneurysm repairArterial flowChronic obstructive pulmonary diseaseBilateral buttock claudicationPreoperative activity levelObstructive pulmonary diseaseBody mass indexIntervention-related changesOVER trialPulmonary diseaseStudy armsMass indexArterial perfusionClaudicationTrial investigatorsAnatomic levelTrial participantsTheoretical riskPatients
2021
Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment
Drekonja DM, Shaukat A, Zhang JH, Reinink AR, Nugent S, Dominitz JA, Davis-Karim A, Gerding DN, Kyriakides TC. Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment. Clinical Trials 2021, 18: 622-629. PMID: 34154439, DOI: 10.1177/17407745211021198.Peer-Reviewed Original ResearchConceptsClinical trialsCase identificationRecurrent infectionsIndividuals meeting inclusion criteriaVeterans Affairs Corporate Data WarehouseFrequent antimicrobial usePrevention of recurrentRecurrent Clostridioides difficileSuccessful initial treatmentFecal microbiota transplantationIncidence of recurrentVeterans Affairs systemFecal microbiota transplantNationwide clinical trialMeeting inclusion criteriaQuality of lifeCorporate Data WarehouseTransplant administrationPrimary endpointStandard therapySubstantial morbidityInitial treatmentCapsule administrationMicrobiota transplantationRandomized comparison
2019
Open versus Endovascular Repair of Abdominal Aortic Aneurysm
Lederle FA, Kyriakides TC, Stroupe KT, Freischlag JA, Padberg FT, Matsumura JS, Huo Z, Johnson GR. Open versus Endovascular Repair of Abdominal Aortic Aneurysm. New England Journal Of Medicine 2019, 380: 2126-2135. PMID: 31141634, DOI: 10.1056/nejmoa1715955.Peer-Reviewed Original ResearchConceptsEndovascular repair groupOpen repair groupEndovascular repairOpen repairOverall survivalAbdominal aortic aneurysmEuropean trialsAortic aneurysmLong-term overall survivalChronic obstructive lung diseaseWorse long-term outcomesAsymptomatic abdominal aortic aneurysmElective endovascular repairLow perioperative mortalityObstructive lung diseaseTraditional open repairAbdominal aortic aneurysms resultsLong-term outcomesLong-term resultsNumber of patientsLong-term survivalCause mortalityPerioperative mortalityPerioperative periodMore patients
2018
Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial
Edelman EJ, Moore BA, Holt SR, Hansen N, Kyriakides TC, Virata M, Brown ST, Justice AC, Bryant KJ, Fiellin DA, Fiellin LE. Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial. AIDS And Behavior 2018, 23: 211-221. PMID: 30073637, PMCID: PMC6476298, DOI: 10.1007/s10461-018-2241-z.Peer-Reviewed Original ResearchConceptsHIV-positive patientsHeavy drinking daysVACS Index scoreXR-NTXART adherenceDrinking daysIndex scoreUndetectable HIV viral loadCD4 cell countExtended-release naltrexoneDouble-blind placeboHIV viral loadRandomized-controlled trialDrinking outcomesHIV biomarkersSecondary outcomesHIV outcomesPrimary outcomeViral loadAntiretroviral adherenceClinical trialsCell countAlcohol treatmentHIVPatients
2017
Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years
Powell J, Sweeting M, Ulug P, Blankensteijn J, Lederle F, Becquemin J, Greenhalgh R, , Greenhalgh R, Beard J, Buxton M, Brown L, Harris P, Powell J, Rose J, Russell I, Sculpher M, Thompson S, Lilford R, Bell P, Greenhalgh R, Whitaker S, Poole‐Wilson T, Ruckley C, Campbell W, Dean M, Ruttley M, Coles E, Powell J, Halliday A, Gibbs S, Brown L, Epstein D, Sculpher M, Thompson S, Hannon R, Johnston L, Bradbury A, Henderson M, Parvin S, Shepherd D, Greenhalgh R, Mitchell A, Edwards P, Abbott G, Higman D, Vohra A, Ashley S, Robottom C, Wyatt M, Rose J, Byrne D, Edwards R, Leiberman D, McCarter D, Taylor P, Reidy J, Wilkinson A, Ettles D, Clason A, Leen G, Wilson N, Downes M, Walker S, Lavelle J, Gough M, McPherson S, Scott D, Kessell D, Naylor R, Sayers R, Fishwick N, Harris P, Gould D, Walker M, Chalmers N, Garnham A, Collins M, Beard J, Gaines P, Ashour M, Uberoi R, Braithwaite B, Whitaker S, Davies J, Travis S, Hamilton G, Platts A, Shandall A, Sullivan B, Sobeh M, Matson M, Fox A, Orme R, Yusef W, Doyle T, Horrocks M, Hardman J, Blair P, Ellis P, Morris G, Odurny A, Vohra R, Duddy M, Thompson M, Loosemore T, Belli A, Morgan R, Adiseshiah M, Brookes J, McCollum C, Ashleigh R, Aukett M, Baker S, Barbe E, Batson N, Bell J, Blundell J, Boardley D, Boyes S, Brown O, Bryce J, Carmichael M, Chance T, Coleman J, Cosgrove C, Curran G, Dennison T, Devine C, Dewhirst N, Errington B, Farrell H, Fisher C, Fulford P, Gough M, Graham C, Hooper R, Horne G, Horrocks L, Hughes B, Hutchings T, Ireland M, Judge C, Kelly L, Kemp J, Kite A, Kivela M, Lapworth M, Lee C, Linekar L, Mahmood A, March L, Martin J, Matharu N, McGuigen K, Morris‐Vincent P, Murray S, Murtagh A, Owen G, Ramoutar V, Rippin C, Rowley J, Sinclair J, Spencer S, Taylor V, Tomlinson C, Ward S, Wealleans V, West J, White K, Williams J, Wilson L, Grobbee D, Blankensteijn J, Bak A, Buth J, Pattynama P, Verhoeven E, van Voorthuisen A, Blankensteijn J, Balm R, Buth J, Cuypers P, Grobbee D, Prinssen M, van Sambeek M, Verhoeven E, Baas A, Hunink M, van Engelshoven J, Jacobs M, de Mol B, van Bockel J, Balm R, Reekers J, Tielbeek X, Verhoeven E, Wisselink W, Boekema N, Heuveling L, Sikking I, Prinssen M, Balm R, Blankensteijn J, Buth J, Cuypers P, van Sambeek M, Verhoeven E, de Bruin J, Baas A, Blankensteijn J, Prinssen M, Buth J, Tielbeek A, Blankensteijn J, Balm R, Reekers J, van Sambeek M, Pattynama P, Verhoeven E, Prins T, van der Ham A, van der Velden J, van Sterkenburg S, ten Haken G, Bruijninckx C, van Overhagen H, Tutein Nolthenius R, Hendriksz T, Teijink J, Odink H, de Smet A, Vroegindeweij D, van Loenhout R, Rutten M, Hamming J, Lampmann L, Bender M, Pasmans H, Vahl A, de Vries C, Mackaay A, van Dortmont L, van der Vliet A, Schultze Kool L, Boomsma J, van Dop H, de Mol van Otterloo J, de Rooij T, Smits T, Yilmaz E, Wisselink W, van den Berg F, Visser M, van der Linden E, Schurink G, de Haan M, Smeets H, Stabel P, van Elst F, Poniewierski J, Vermassen F, Lederle F, Freischlag J, Kohler T, Latts E, Matsumura J, Padberg F, Kyriakides T, Swanson K, Guarino P, Peduzzi P, Antonelli M, Cushing C, Davis E, Durant L, Joyner S, Kossack T, Kyriakides T, LeGwin M, McBride V, O'Connor T, Poulton J, Stratton T, Zellner S, Snodgrass A, Thornton J, Swanson K, Haakenson C, Stroupe K, Jonk Y, Hallett J, Hertzer N, Towne J, Katz D, Karrison T, Matts J, Marottoli R, Kasl S, Mehta R, Feldman R, Farrell W, Allore H, Perry E, Niederman J, Randall F, Zeman M, Beckwith T, O'Leary T, Huang G, Latts E, Bader M, Ketteler E, Kingsley D, Marek J, Massen R, Matteson B, Pitcher J, Langsfeld M, Corson J, Goff J, Kasirajan K, Paap C, Robertson D, Salam A, Veeraswamy R, Milner R, Kasirajan K, Guidot J, Lal B, Busuttil S, Lilly M, Braganza M, Ellis K, Patterson M, Jordan W, Whitley D, Taylor S, Passman M, Kerns D, Inman C, Poirier J, Ebaugh J, Raffetto J, Chew D, Lathi S, Owens C, Hickson K, Dosluoglu H, Eschberger K, Kibbe M, Baraniewski H, Matsumura J, Endo M, Busman A, Meadows W, Evans M, Giglia J, El Sayed H, Reed A, Ruf M, Ross S, Jean‐Claude J, Pinault G, Kang P, White N, Eiseman M, Jones T, Timaran C, Modrall J, Welborn M, Lopez J, Nguyen T, Chacko J, Granke K, Vouyouka A, Olgren E, Chand P, Allende B, Ranella M, Yales C, Whitehill T, Krupski T, Nehler M, Johnson S, Jones D, Strecker P, Bhola M, Shortell C, Gray J, Lawson J, McCann R, Sebastian M, Kistler Tetterton J, Blackwell C, Prinzo P, Lee N, Padberg F, Cerveira J, Lal B, Zickler R, Hauck K, Berceli S, Lee W, Ozaki C, Nelson P, Irwin A, Baum R, Aulivola B, Rodriguez H, Littooy F, Greisler H, O'Sullivan M, Kougias P, Lin P, Bush R, Guinn G, Bechara C, Cagiannos C, Pisimisis G, Barshes N, Pillack S, Guillory B, Cikrit D, Lalka S, Lemmon G, Nachreiner R, Rusomaroff M, O'Brien E, Cullen J, Hoballah J, Sharp W, McCandless J, Beach V, Minion D, Schwarcz T, Kimbrough J, Ashe L, Rockich A, Warner‐Carpenter J, Moursi M, Eidt J, Brock S, Bianchi C, Bishop V, Gordon I, Fujitani R, Kubaska S, Behdad M, Azadegan R, Ma Agas C, Zalecki K, Hoch J, Carr S, Acher C, Schwarze M, Tefera G, Mell M, Dunlap B, Rieder J, Stuart J, Weiman D, Abul‐Khoudoud O, Garrett H, Walsh S, Wilson K, Seabrook G, Cambria R, Brown K, Lewis B, Framberg S, Kallio C, Barke R, Santilli S, d'Audiffret A, Oberle N, Proebstle C, Johnson L, Jacobowitz G, Cayne N, Rockman C, Adelman M, Gagne P, Nalbandian M, Caropolo L, Pipinos I, Johanning J, Lynch T, DeSpiegelaere H, Purviance G, Zhou W, Dalman R, Lee J, Safadi B, Coogan S, Wren S, Bahmani D, Maples D, Thunen S, Golden M, Mitchell M, Fairman R, Reinhardt S, Wilson M, Tzeng E, Muluk S, Peterson N, Foster M, Edwards J, Moneta G, Landry G, Taylor L, Yeager R, Cannady E, Treiman G, Hatton‐Ward S, Salabsky T, Kansal N, Owens E, Estes M, Forbes B, Sobotta C, Rapp J, Reilly L, Perez S, Yan K, Sarkar R, Dwyer S, Perez S, Chong K, Kohler T, Hatsukami T, Glickerman D, Sobel M, Burdick T, Pedersen K, Cleary P, Back M, Bandyk D, Johnson B, Shames M, Reinhard R, Thomas S, Hunter G, Leon L, Westerband A, Guerra R, Riveros M, Mills J, Hughes J, Escalante A, Psalms S, Day N, Macsata R, Sidawy A, Weiswasser J, Arora S, Jasper B, Dardik A, Gahtan V, Muhs B, Sumpio B, Gusberg R, Spector M, Pollak J, Aruny J, Kelly E, Wong J, Vasilas P, Joncas C, Gelabert H, DeVirgillio C, Rigberg D, Cole L, Becquemin J, Marzelle J, Becquemin J, Sapoval M, Becquemin J, Favre J, Watelet J, Lermusiaux P, Sapoval M, Lepage E, Hemery F, Dolbeau G, Hawajry N, Cunin P, Harris P, Stockx L, Chatellier G, Mialhe C, Fiessinger J, Pagny L, Kobeiter H, Boissier C, Lacroix P, Ledru F, Pinot J, Deux J, Tzvetkov B, Duvaldestin P, Watelet J, Jourdain C, David V, Enouf D, Ady N, Krimi A, Boudjema N, Jousset Y, Enon B, Blin V, Picquet J, L'Hoste P, Thouveny F, Borie H, Kowarski S, Pernes J, Auguste M, Becquemin J, Desgranges P, Allaire E, Marzelle J, Kobeiter H, Meaulle P, Chaix D, Juliae P, Fabiani J, Chevalier P, Combes M, Seguin A, Belhomme D, Sapoval M, Baque J, Pellerin O, Favre J, Barral X, Veyret C, Watelet J, Peillon C, Plissonier D, Thomas P, Clavier E, Lermusiaux P, Martinez R, Bleuet F, C D, Verhoye J, Langanay T, Heautot J, Koussa M, Haulon S, Halna P, Destrieux L, Lions C, Wiloteaux S, Beregi J, Bergeron P, Pinot J, Patra P, Costargent A, Chaillou P, D'Alicourt A, Goueffic Y, Cheysson E, Parrot A, Garance P, Demon A, Tyazi A, Pillet J, Lescalie F, Tilly G, Steinmetz E, Favier C, Brenot R, Krause D, Cercueil J, Vahdat O, Sauer M, Soula P, Querian A, Garcia O, Levade M, Colombier D, Cardon J, Joyeux A, Borrelly P, Dogas G, Magnan P, Branchereau A, Bartoli J, Hassen‐Khodja R, Batt M, Planchard P, Bouillanne P, Haudebourg P, Bayne J, Gouny P, Badra A, Braesco J, Nonent M, Lucas A, Cardon A, Kerdiles Y, Rolland Y, Kassab M, Brillu C, Goubault F, Tailboux L, Darrieux H, Briand O, Maillard J, Varty K, Cousins C. Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. British Journal Of Surgery 2017, 104: 166-178. PMID: 28160528, PMCID: PMC5299468, DOI: 10.1002/bjs.10430.Peer-Reviewed Original ResearchConceptsElective endovascular aneurysm repairEarly survival advantageEVAR groupOpen repairIndividual patient dataAbdominal aortic aneurysmSurvival advantageEVAR-1Artery diseaseAortic aneurysmPrevious coronary artery diseaseBrachial pressure indexModerate renal dysfunctionPeripheral artery diseaseCoronary artery diseaseEndovascular aneurysm repairPrespecified analysis planOperative mortalityRenal dysfunctionAneurysm repairEarly mortalityACE trialLower ankleLower mortalityMortality advantage
2015
Predictors and outcomes of endoleaks in the Veterans Affairs Open Versus Endovascular Repair (OVER) Trial of Abdominal Aortic Aneurysms
Lal BK, Zhou W, Li Z, Kyriakides T, Matsumura J, Lederle FA, Freischlag J, Group O. Predictors and outcomes of endoleaks in the Veterans Affairs Open Versus Endovascular Repair (OVER) Trial of Abdominal Aortic Aneurysms. Journal Of Vascular Surgery 2015, 62: 1394-1404. PMID: 26598115, DOI: 10.1016/j.jvs.2015.02.003.Peer-Reviewed Original ResearchConceptsType II endoleakEndovascular repairSecondary interventionsAortic aneurysmRisk factorsAneurysm sizeVeterans AffairsKaplan-Meier survival analysisInitial aneurysm sizeStandard-risk patientsSuccessful endovascular repairType of endoleakVascular risk factorsInfrarenal aortic aneurysmLong-term outcomesAnalysis of patientsLength of survivalAbdominal aortic aneurysmPresence of endoleaksLogistic regression analysisDiameter enlargementOVER trialPatient demographicsEndoleak developmentLong follow
2012
Long-Term Comparison of Endovascular and Open Repair of Abdominal Aortic Aneurysm
Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg FT, Kohler TR, Kougias P, Jean-Claude JM, Cikrit DF, Swanson KM. Long-Term Comparison of Endovascular and Open Repair of Abdominal Aortic Aneurysm. New England Journal Of Medicine 2012, 367: 1988-1997. PMID: 23171095, DOI: 10.1056/nejmoa1207481.Peer-Reviewed Original ResearchConceptsEndovascular repair groupOpen repair groupAbdominal aortic aneurysmYears of ageEndovascular repairOpen repairLong-term survivalAortic aneurysmSimilar long-term survivalAsymptomatic abdominal aortic aneurysmVeterans Affairs Medical CenterElective endovascular repairLong-term morbidityTraditional open repairType of treatmentCause mortalityPerioperative mortalityTime of registrationOlder patientsYounger patientsEndovascular approachPrimary outcomeAneurysm ruptureMedical CenterSurvival advantageCost-effectiveness of open versus endovascular repair of abdominal aortic aneurysm in the OVER trial
Stroupe KT, Lederle FA, Matsumura JS, Kyriakides TC, Jonk YC, Ge L, Freischlag JA, Group O. Cost-effectiveness of open versus endovascular repair of abdominal aortic aneurysm in the OVER trial. Journal Of Vascular Surgery 2012, 56: 901-909.e2. PMID: 22640466, DOI: 10.1016/j.jvs.2012.01.086.Peer-Reviewed Original ResearchConceptsTotal health care costsEndovascular repair groupEndovascular groupHealth care providersHealth care costsRepair groupEndovascular repairMean total health care costsCare costsAbdominal aortic aneurysm repairPatient's health care providersVeterans Affairs Cooperative StudyHealth care utilization dataVA Health Economics Resource CenterOpen repair groupAortic aneurysm repairEndovascular AAA repairNon-VA careLength of stayAbdominal aortic aneurysmLower mean costQuality of lifeGraft costsMedicare data sourcesOVER trialPredictive value of HIV‐1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment‐experienced patients
Bedimo R, Kyriakides T, Brown S, Weidler J, Lie Y, Coakley E, Holodniy M. Predictive value of HIV‐1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment‐experienced patients. HIV Medicine 2012, 13: 345-351. PMID: 22276745, DOI: 10.1111/j.1468-1293.2011.00981.x.Peer-Reviewed Original ResearchConceptsCD4 cell countViral load changesWeek 12Replication capacityPredictive valueCell countCD4 cell count responseHIV-1 replication capacityAntiretroviral treatment responseHIV replication capacityImmediate salvage therapyPhenotypic susceptibility scoresDrug-free periodPhenotypic resistance testingCell count responseAdditional predictive valueMultivariate regression analysisTreatment reinitiationSalvage therapyWeek 24ARV therapyViral loadPrognostic valueARV treatmentAntiretroviral trials
2007
Evolution of Genotypic Resistance Algorithms and Their Impact on the Interpretation of Clinical Trials: An OPTIMA Trial Substudy
Desai S, Kyriakides T, Holodniy M, Al-Salman J, Griffith B, Kozal M. Evolution of Genotypic Resistance Algorithms and Their Impact on the Interpretation of Clinical Trials: An OPTIMA Trial Substudy. HIV Research & Clinical Practice 2007, 8: 293-302. PMID: 17956830, DOI: 10.1310/hct0805-293.Peer-Reviewed Original ResearchMeSH KeywordsAlgorithmsAnti-HIV AgentsDrug Resistance, ViralFemaleGenes, polHIV InfectionsHIV-1HumansMaleMiddle AgedTreatment OutcomeVirologyConceptsLong-term clinical trialsGenotypic resistance algorithmsClinical trialsDisease progressionHIV disease progression ratesHIV-1 pol sequencesHIV disease progressionDisease progression rateResistance algorithmsVirologic responseDrug comparisonsProgression rateVirtual phenotypeGenotypic algorithmsPol sequencesPatientsDrug resistanceResistance interpretationTrialsProgressionDrugsExpected ratesViral sequencesFirst eventSimilar time